These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10960160)

  • 21. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Rose N; Heidenreich T; Jelinek L; Alsleben H; Wahl K; Philipsen A; Voderholzer U; Maier JG; Moritz S
    Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):223-233. PubMed ID: 30446822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smaller volume of posterior thalamic nuclei in patients with obsessive-compulsive disorder.
    Jurng J; Park H; Kim T; Park I; Moon SY; Lho SK; Kim M; Kwon JS
    Neuroimage Clin; 2021; 30():102686. PubMed ID: 34215156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary volume in pediatric obsessive-compulsive disorder.
    MacMaster FP; Russell A; Mirza Y; Keshavan MS; Banerjee SP; Bhandari R; Boyd C; Lynch M; Rose M; Ivey J; Moore GJ; Rosenberg DR
    Biol Psychiatry; 2006 Feb; 59(3):252-7. PubMed ID: 16140279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis.
    Wu Y; Lang Z; Zhang H
    Med Sci Monit; 2016 May; 22():1646-53. PubMed ID: 27182928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic Subregions and Obsessive-Compulsive Symptoms in 2,500 Children From the General Population.
    Weeland CJ; Vriend C; van der Werf Y; Huyser C; Hillegers M; Tiemeier H; White T; van den Heuvel OA
    J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):321-330. PubMed ID: 34217835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adapted cognitive behavior therapy for obsessive-compulsive disorder with co-occurring autism spectrum disorder: A clinical effectiveness study.
    Flygare O; Andersson E; Ringberg H; Hellstadius AC; Edbacken J; Enander J; Dahl M; Aspvall K; Windh I; Russell A; Mataix-Cols D; Rück C
    Autism; 2020 Jan; 24(1):190-199. PubMed ID: 31187645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of an adolescent with obsessive-compulsive disorder by alternating response prevention and cognitive therapy: an empirical analysis.
    Kearney CA; Silverman WK
    J Behav Ther Exp Psychiatry; 1990 Mar; 21(1):39-47. PubMed ID: 2373767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT.
    Huyser C; Veltman DJ; Wolters LH; de Haan E; Boer F
    J Child Psychol Psychiatry; 2011 Dec; 52(12):1251-60. PubMed ID: 21793825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary study of cognitive-behavioral family-based treatment versus parent training for young children with obsessive-compulsive disorder.
    Rosa-Alcázar AI; Iniesta-Sepúlveda M; Storch EA; Rosa-Alcázar Á; Parada-Navas JL; Olivares Rodríguez J
    J Affect Disord; 2017 Jan; 208():265-271. PubMed ID: 27792972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of cognitive-coping therapy and alteration of resting-state brain function in obsessive-compulsive disorder.
    Zhao HZ; Wang CH; Gao ZZ; Ma JD; Huang P; Li HF; Sang DE; Shan XW; Kou SJ; Li ZR; Ma L; Zhang ZH; Zhang JH; Ouyang H; Lian HK; Zang YF; Hu XZ
    J Affect Disord; 2017 Jan; 208():184-190. PubMed ID: 27792961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorder.
    Rotge JY; Dilharreguy B; Aouizerate B; Martin-Guehl C; Guehl D; Jaafari N; Langbour N; Bioulac B; Tignol J; Allard M; Burbaud P
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):682-7. PubMed ID: 19306905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder.
    Szeszko PR; MacMillan S; McMeniman M; Chen S; Baribault K; Lim KO; Ivey J; Rose M; Banerjee SP; Bhandari R; Moore GJ; Rosenberg DR
    Am J Psychiatry; 2004 Jun; 161(6):1049-56. PubMed ID: 15169693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary gland volumes in patients with obsessive-compulsive disorder before and after cognitive-behavioral therapy.
    Atmaca M; Yildirim H; Yilmaz S; Caglar N; Baykara S; Kekilli Y; Koseoglu F; Turkcapar H
    Braz J Psychiatry; 2018; 40(4):420-423. PubMed ID: 29898196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How can technology enhance cognitive behavioral therapy: the case of pediatric obsessive compulsive disorder.
    Wolters LH; Op de Beek V; Weidle B; Skokauskas N
    BMC Psychiatry; 2017 Jun; 17(1):226. PubMed ID: 28645268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inferior thalamic peduncle deep brain stimulation for treatment-refractory obsessive-compulsive disorder: A phase 1 pilot trial.
    Lee DJ; Dallapiazza RF; De Vloo P; Elias GJB; Fomenko A; Boutet A; Giacobbe P; Lozano AM
    Brain Stimul; 2019; 12(2):344-352. PubMed ID: 30514614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of treatment response to group cognitive behavioural therapy for pediatric obsessive-compulsive disorder.
    Lavell CH; Farrell LJ; Waters AM; Cadman J
    Psychiatry Res; 2016 Nov; 245():186-193. PubMed ID: 27544784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive behavioral therapy for obsessive-compulsive disorder: an update.
    Huppert JD; Franklin ME
    Curr Psychiatry Rep; 2005 Aug; 7(4):268-73. PubMed ID: 16098280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The drug-naïve OCD patients imaging genetics, cognitive and treatment response study: methods and sample description.
    Hoexter MQ; Shavitt RG; D'Alcante CC; Cecconi JP; Diniz JB; Belotto-Silva C; Hounie AG; Borcato S; Moraes I; Joaquim MA; Cappi C; Sampaio AS; Mathis MA; Batistuzzo MC; Lopes AC; Rosa AC; Muniz RK; Marques AH; Santos LC; Taub A; Duran FL; Dougherty DD; Busatto GF; Bressan RA; Miguel EC
    Braz J Psychiatry; 2009 Dec; 31(4):349-53. PubMed ID: 20098825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder - a process-outcome study.
    Diedrich A; Sckopke P; Schwartz C; Schlegl S; Osen B; Stierle C; Voderholzer U
    BMC Psychiatry; 2016 Jul; 16():220. PubMed ID: 27388205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.